GURUNANDA NASAL SALINE
NDC 70708-210, NASAL WASH, powder, for solution, from GURUNANDA LLC.
- Product NDC
- 70708-210
- Status
- Listed
- Labeler
- GURUNANDA LLC
- Dosage form
- POWDER, FOR SOLUTION
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70708-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM BICARBONATE.515 g/2.2g
- SODIUM CHLORIDE1.685 g/2.2g
Pharmacologic classes
Alkalinizing Activity [MoA]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70708-210-08 | 70708021008 | 8 PACKET in 1 BOX (70708-210-08) / 2.2 g in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70708-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70708-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70708-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.